Title
High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in anal and pharyngeal sites among a community-based sample of men who have sex with men and transgender women in Lima, Peru
Date Issued
01 January 2016
Access level
open access
Resource Type
journal article
Publisher(s)
BMJ Publishing Group
Abstract
Objectives: This study aimed to characterise the epidemiology of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections among men who have sex with men (MSM) and transgender women (TW) in Lima, Peru. Setting: Cross-sectional study in Lima, Peru. Participants: We recruited a group of 510 MSM and 208 TW for a subsequent community-based randomised controlled trial. The presence of CT and NG were evaluated using Aptima Combo2 in pharyngeal and anal swabs. We also explored correlates of these infections. Primary and secondary outcome measures: Study end points included overall prevalence of C. trachomatis and N. gonorrhoeae in anal and pharyngeal sites. Results: Overall prevalence of CT was 19% (95% CI 16.1% to 22.1%) and 4.8% (95% CI 3.3% to 6.6%) in anal and pharyngeal sites, respectively, while prevalence of NG was 9.6% (95% CI 7.5% to 12.0%) and 6.5% (95% CI 4.8% to 8.5%) in anal and pharyngeal sites, respectively. Conclusions: The prevalence of each infection declined significantly among participants older than 34 years (p<0.05). Efforts towards prevention and treatment of extraurogenital chlamydial and gonococcal infections in high-risk populations like MSM and TW in Lima, Peru, are warranted. Trial registration number: NCT00670163; Results.
Volume
6
Issue
1
Language
English
OCDE Knowledge area
Urología, Nefrología
Scopus EID
2-s2.0-84960192619
PubMed ID
Source
BMJ Open
ISSN of the container
2044-6055
Sponsor(s)
This work was supported by the US National Institute of Mental Health grant number 5R01MH078752. SRL was also supported by NIH research training grant #r25 tw009345 funded by the Fogarty International Center, the National Institute of Mental Health, the NIH Office of the Director, the Office of Women''s Health and the Office of AIDS Research.
Sources of information: Directorio de Producción Científica Scopus